BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 12438534)

  • 1. Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary intervention.
    Day JR; Malik IS; Weerasinghe A; Poullis M; Nadra I; Haskard DO; Taylor KM; Landis RC
    Heart; 2004 Jul; 90(7):794-9. PubMed ID: 15201252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking Computational Fluid Dynamics Modeling to Device-Induced Platelet Defects in Mechanically Assisted Circulation.
    Zhang J; Han D; Chen Z; Wang S; Sun W; Griffith BP; Wu ZJ
    ASAIO J; 2024 May; ():. PubMed ID: 38768482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of cellular traction forces via the force-triggered Cas12a-mediated catalytic cleavage of a fluorogenic reporter strand.
    Duan Y; Szlam F; Hu Y; Chen W; Li R; Ke Y; Sniecinski R; Salaita K
    Nat Biomed Eng; 2023 Nov; 7(11):1404-1418. PubMed ID: 37957275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanically Triggered Hybridization Chain Reaction.
    Duan Y; Glazier R; Bazrafshan A; Hu Y; Rashid SA; Petrich BG; Ke Y; Salaita K
    Angew Chem Int Ed Engl; 2021 Sep; 60(36):19974-19981. PubMed ID: 34242462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-Based Microparticle Tension Sensors (μTS) for Measuring Cell Mechanics in Non-planar Geometries and for High-Throughput Quantification.
    Hu Y; Ma VP; Ma R; Chen W; Duan Y; Glazier R; Petrich BG; Li R; Salaita K
    Angew Chem Int Ed Engl; 2021 Aug; 60(33):18044-18050. PubMed ID: 33979471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothermia: effects on platelet function and hemostasis.
    Van Poucke S; Stevens K; Marcus AE; Lancé M
    Thromb J; 2014; 12(1):31. PubMed ID: 25506269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abciximab: an updated review of its therapeutic use in patients with ischaemic heart disease undergoing percutaneous coronary revascularisation.
    Ibbotson T; McGavin JK; Goa KL
    Drugs; 2003; 63(11):1121-63. PubMed ID: 12749745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet glycoprotein IIb/IIIa antagonists: lessons learned from clinical trials and future directions.
    Leclerc JR
    Crit Care Med; 2002 May; 30(5 Suppl):S332-40. PubMed ID: 12004256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of the intravenous platelet receptor glycoprotein IIb-IIIa antagonists.
    Kleiman NS
    Coron Artery Dis; 1998; 9(9):603-16. PubMed ID: 9861523
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative analysis of various platelet glycoprotein IIb/IIIa antagonists on shear-induced platelet activation and adhesion.
    Wang X; Dorsam RT; Lauver A; Wang H; Barbera FA; Gibbs S; Varon D; Savion N; Friedman SM; Feuerstein GZ
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1114-20. PubMed ID: 12438534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential antiplatelet efficacy for various GPIIb/IIIa antagonists: role of plasma calcium levels.
    Mousa SA; Bozarth JM; Forsythe MS; Slee A
    Cardiovasc Res; 2000 Sep; 47(4):819-26. PubMed ID: 10974231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists.
    Mousa SA; Khurana S; Forsythe MS
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1162-7. PubMed ID: 10764688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy between the glycoprotein IIb/IIIa antagonists roxifiban and orbofiban in inhibiting platelet responses in flow models of thrombosis.
    Mousa SA; Abulencia JP; McCarty OJ; Turner NA; Konstantopoulos K
    J Cardiovasc Pharmacol; 2002 Apr; 39(4):552-60. PubMed ID: 11904529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AlphaIIbbeta3 priming and clustering by orally active and intravenous integrin antagonists.
    Hantgan RR; Stahle MC; Connor JH; Connor RF; Mousa SA
    J Thromb Haemost; 2007 Mar; 5(3):542-50. PubMed ID: 17166246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glycoprotein IIb/IIIa antagonists on platelet activation: development of a transfer method to mimic peak to trough receptor occupancy.
    Billheimer JT; He B; Spitz SM; Stern AM; Seiffert D
    Thromb Res; 2002 Sep; 107(6):303-17. PubMed ID: 12565717
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.